U.S. CDC ADVISERS VOTE IN FAVOR OF RECOMMENDING PFIZER-BIONTECH COVID-19 VACCINE BOOSTER DOSE FOR 12–17 YEAR OLDS, AT LEAST 5 MONTHS AFTER SECOND DOSE
Stock Market News
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
28.92 USD | +0.91% | +3.10% | 164B | ||
- Stock Market
- Stock Market News
- Economy
- U.s. Cdc Advisers Vote In Favor Of Recommending Pfizer-Biontech Covid-19 Vaccine Booster Dose For 12–17 Year Olds, At Least 5 Months After Second Dose